Repligen (RGEN) Stock
Repligen (RGEN) closed at $162.18 on Nov 17, 2026; its Tenet Score is 49 of 100 against 340 Healthcare peers.
8 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $162.18
- Nov 17, 2026
- Market cap
- $10.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 100.99 – 198.87
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 49/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Repligen Corp. scores 49/100. Mixed. Value is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ✓ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding compon…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Dr. Reddy's Laboratories Ltd.RDY | 45 | $12.3B |
| Bio-Techne CorpTECH | 51 | $11.4B |
| Biomarin Pharmaceutical Inc.BMRN | 43 | $11.2B |
| Halozyme Therapeutics Inc.HALO | 71 | $11.0B |
| Kymera Therapeutics IncKYMR | 41 | $10.7B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.8B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Spyre Therapeutics Inc.SYRE | 43 | $9.4B |
| Krystal Biotech IncKRYS | 66 | $8.8B |
| Praxis Precision Medicines IncPRAX | 46 | $8.7B |
Common questions
What sector and industry is Repligen in?
Repligen is in the Healthcare sector and the Drugs industry.
What is Repligen's Tenet Score?
Repligen's Tenet Score is 49 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




